Company intelligence / Profile preview

Gema Diagnostics

East Lansing, Michigan, United Statesmichiganvca.org ↗

Ownership: Private
Development stage: Other

Overview

Gema Diagnostics develops molecular diagnostic technologies to support assisted reproductive technologies. The company focuses on improving outcomes in fertility treatments using advanced genetic and molecular analysis. No clinical trial results are reported as it provides diagnostic tools rather than therapeutics.

Therapeutic areas: Women's Health
Modalities: Molecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Gema Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gema Diagnostics.

Explore the full profile